Project cooperationUpdated on 19 January 2026
Multi-omics integration in genome-scale metabolic models
Tenured professor at Computational Systems Biology team, Rīga Stradiņš University
Riga, Latvia
About
Genome-scale metabolic models enable comparison of healthy and diseased tissues, samples before and after therapy as well as other analyses where it is necessary to identify differences in metabolic network performance.
Another aspect is the genome-scale metabolic model based (in silico)development of combinatorial therapies.
The same can be done with cell culture and organoid samples.
Organisation
Similar opportunities
Project cooperation
In silico combinatorial therapy ranking
Egils Stalidzans
Tenured professor at Computational Systems Biology team, Rīga Stradiņš University
Riga, Latvia
Project cooperation
Mass Spetrometry Metabolomics: Bioactive Metabolites and Host-Microbiota Interactions
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
Zdenek Kamenik
Research group leader at Institute of Microbiology Czech Acad Sci
Praha, Czech Republic
Project cooperation
- Consortium/Coordinator seeks Partners
- Partner seeks Consortium/Coordinator
- DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-04: Towards climate resilient, prepared and carbon neutral populations and healthcare systems
- DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
MARTA SANS VALLS
European Programme Manager at Fundacio Eurecat
Barcelona, Spain